Cadila Healthcare shares rise 3% on DCGI nod to Phase III clinical trials of COVID-19 vaccine

In Phase II, the vaccine ZyCoV-D was found to be safe and elicited a strong immunogenic response.

from Moneycontrol Latest News https://ift.tt/2KWYf8l